U. Wolf

Transformation by Oncogenic Mutants and Ligand-Dependent Activation of FLT3 Wild-type Requires the Tyrosine Residues 589 and 591

W. Hiddemann, C. Buske, K. Spiekermann, 2008, Clinical Cancer Research.